Literature DB >> 17235240

Gene-specific fluorescence in-situ hybridization analysis on tissue microarray to refine the region of chromosome 20q amplification in melanoma.

Denitsa K Koynova1, Ekaterina S Jordanova, Angel D Milev, Remco Dijkman, Krassimir S Kirov, Draga I Toncheva, Nelleke A Gruis.   

Abstract

Several comparative genomic hybridization studies provide evidence for overrepresentation of the long arm of chromosome 20 in malignant melanoma. These studies also suggest that chromosome 20q contains genes that may contribute to melanoma pathogenesis. To refine the region of 20q amplification and to identify potential candidate genes involved in melanoma or even in melanoma progression from these regions, we combined fluorescence in-situ hybridization with MYBL2, ZNF217, CYP24 and STK6 specific probes (chromosomal region 20q13.1-q13.2) with high-throughput tissue microarray consisting of 280 primary melanomas and melanoma metastases. Low-level amplification ranging from 0.5 to 2.0% was detected for the tumor-related genes of interest. Higher frequencies of gain when compared with amplification were detected for MYBL2, ZNF217, CYP24 and STK6. Aneusomy of centromere 20 was observed in 29.9% of the analyzed tumors. A significantly higher frequency of ZNF217, CYP24 and STK6 total copy-number increase, as well as aneusomy of centromere 20, was found in the group of metastases when compared with the group of primary melanomas. Despite the technological advantage of fluorescence in-situ hybridization on tissue microarray, which allows refining regions of amplification, we were not able to recognize any of the MYBL2, ZNF217, CYP24 and STK6 genes as a particular relevant gene for melanoma tumorigenesis.

Entities:  

Mesh:

Year:  2007        PMID: 17235240     DOI: 10.1097/CMR.0b013e3280141617

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  9 in total

1.  The potential role of vitamin D in the progression of benign and malignant melanocytic neoplasms.

Authors:  Joel Pinczewski; Andrzej Slominski
Journal:  Exp Dermatol       Date:  2010-10       Impact factor: 3.960

2.  Multiple genes identified as targets for 20q13.12-13.33 gain contributing to unfavorable clinical outcomes in patients with hepatocellular carcinoma.

Authors:  Dong Wang; Zhong-Zheng Zhu; Hongmei Jiang; Jiayi Zhu; Wen-Ming Cong; Bing-Ji Wen; Song-Qin He; Shu-Fang Liu
Journal:  Hepatol Int       Date:  2015-06-12       Impact factor: 6.047

Review 3.  Achilles' heel of pluripotent stem cells: genetic, genomic and epigenetic variations during prolonged culture.

Authors:  Paola Rebuzzini; Maurizio Zuccotti; Carlo Alberto Redi; Silvia Garagna
Journal:  Cell Mol Life Sci       Date:  2016-03-09       Impact factor: 9.261

4.  Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture.

Authors:  Louise C Laurent; Igor Ulitsky; Ileana Slavin; Ha Tran; Andrew Schork; Robert Morey; Candace Lynch; Julie V Harness; Sunray Lee; Maria J Barrero; Sherman Ku; Marina Martynova; Ruslan Semechkin; Vasiliy Galat; Joel Gottesfeld; Juan Carlos Izpisua Belmonte; Chuck Murry; Hans S Keirstead; Hyun-Sook Park; Uli Schmidt; Andrew L Laslett; Franz-Josef Muller; Caroline M Nievergelt; Ron Shamir; Jeanne F Loring
Journal:  Cell Stem Cell       Date:  2011-01-07       Impact factor: 24.633

5.  Genetic alterations in RAS-regulated pathway in acral lentiginous melanoma.

Authors:  Joan A Puig-Butillé; Celia Badenas; Zighereda Ogbah; Cristina Carrera; Paula Aguilera; Josep Malvehy; Susana Puig
Journal:  Exp Dermatol       Date:  2013-02       Impact factor: 3.960

6.  Cancer biomarker discovery: the entropic hallmark.

Authors:  Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-08-18       Impact factor: 3.240

7.  Aggressiveness of human melanoma xenograft models is promoted by aneuploidy-driven gene expression deregulation.

Authors:  Véronique Mathieu; Christine Pirker; Wolfgang M Schmidt; Sabine Spiegl-Kreinecker; Daniela Lötsch; Petra Heffeter; Balazs Hegedus; Michael Grusch; Robert Kiss; Walter Berger
Journal:  Oncotarget       Date:  2012-04

8.  Increased AURKA Gene Copy Number Correlates with Poor Prognosis and Predicts the Efficacy of High-dose Interferon Therapy in Acral Melanoma.

Authors:  Junya Yan; Jiayi Yu; Xiaowen Wu; Tianxiao Xu; Huan Yu; Jie Dai; Meng Ma; Huan Tang; Longwen Xu; Zhihong Chi; Lu Si; Xinan Sheng; Chuanliang Cui; Yan Kong; Jun Guo
Journal:  J Cancer       Date:  2018-03-15       Impact factor: 4.207

9.  Identification of aberrantly methylated differentially expressed genes and pro-tumorigenic role of KIF2C in melanoma.

Authors:  Chun-Hui Huang; Wei Han; Yi-Zhu Wu; Guo-Liang Shen
Journal:  Front Genet       Date:  2022-07-22       Impact factor: 4.772

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.